User profiles for C. Mori

Claudio Mori

Vifor Pharma
Verified email at viforpharma.com
Cited by 5508

Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron‐deficient heart failure patients: an individual patient data meta‐analysis

…, GP Arutyunov, M Motro, C Mori… - European journal of …, 2018 - Wiley Online Library
Aims Iron deficiency ( ID ) is a common co‐morbidity in patients with heart failure ( HF ) and
has been suggested to be associated with poor prognosis. Recently completed double‐blind …

Association of sexting with sexual behaviors and mental health among adolescents: A systematic review and meta-analysis

C Mori, JR Temple, D Browne, S Madigan - JAMA pediatrics, 2019 - jamanetwork.com
C. Bias in meta-analysis detected by a simple, graphical test. … Camille Mori was supported
by a graduate scholarship from the Social Sciences and Humanities Research Council (…

[HTML][HTML] Ferric carboxymaltose in patients with heart failure and iron deficiency

…, J Niegowska, BA Kirwan, C Mori… - … England Journal of …, 2009 - Mass Medical Soc
Background Iron deficiency may impair aerobic performance. This study aimed to determine
whether treatment with intravenous iron (ferric carboxymaltose) would improve symptoms in …

Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor

Y Uehara, O Minowa, C Mori, K Shiota, J Kuno, T Noda… - Nature, 1995 - nature.com
… ES cells that carry two targeted alleles of the c-met gene: c-met T/T ES cells cannot contribute
to the liver, but contribute to various other organs. In contrast, c-met "/T ES cells participate …

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency

…, L Tavazzi, V Levesque, C Mori… - European heart …, 2015 - academic.oup.com
Aim The aim of this study was to evaluate the benefits and safety of long-term iv iron therapy
in iron-deficient patients with heart failure (HF). Methods and results CONFIRM-HF was a …

High-dose intravenous gammaglobulin for Kawasaki disease

…, O Hirose, T Yokoyama, K Baba, C Mori - The Lancet, 1984 - Elsevier
The ability of high-dose intravenous gammaglobulin (IVGG) to prevent the coronary artery
lesion of Kawasaki disease has been studied in a multicentre controlled trial of IVGG plus …

Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders.

…, K Tanaka, WZ Wang, C Mori… - Proceedings of the …, 1996 - National Acad Sciences
… For electron microscopy, embryonic hearts were fixed with 2.5% (vol/vol) glutaraldehyde
in 0.1 M sodium phosphate (pH 7.4) for 1 hr at 4C and immersed in 0.1 M sodium phosphate …

Disruption of the mouse RBP-Jк gene results in early embryonic death

…, T Nakano, A Wakeham, JL Pompa, C Mori… - …, 1995 - journals.biologists.com
The RBP-Jк protein is a transcription factor that recog-nizes the sequence C(T)GTGGGGA.
The RBP-Jк gene is highly conserved in a wide variety of species and the Drosophila …

Targeted gene disruption of Hsp70-2 results in failed meiosis, germ cell apoptosis, and male infertility.

DJ Dix, JW Allen, BW Collins, C Mori… - Proceedings of the …, 1996 - National Acad Sciences
In addition to the five 70-kDa heat shock proteins (HSP70) common to germ cells and
somatic tissues of mammals, spermatogenic cells synthesize HSP70-2 during meiosis. To …

Structure and organization of the hepatitis C virus genome isolated from human carriers

A Takamizawa, C Mori, I Fuke, S Manabe… - Journal of …, 1991 - Am Soc Microbiol
Hepatitis C virus (HCV) is a major causative agent of posttransfusion non-A, non-B hepatitis,
which often develops into malignant chronic diseases, including liver cirrhosis and …